After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Rhythm Pharmaceuticals Inc is $7.58B. A total of 1.73 million shares were traded on the day, compared to an average of 699.12K shares.
In the most recent transaction, PAMELA CRAMER bought 3,350 shares of RYTM for 104.77 per share on Dec 11 ’25. In a previous transaction on Nov 20 ’25, Cramer Pamela J. sold 3,350 shares at 105.00 per share. RYTM shares that Chief Human Resources Officer owns now total 20,814.
Among the insiders who bought shares, PAMELA CRAMER acquired of 3,350 shares on Nov 20 ’25 at a per-share price of $103.15. In another insider transaction, Cramer Pamela J. sold 19,351 shares at $98.82 per share on Nov 07 ’25. Company shares held by the Chief Human Resources Officer now total 20,814.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, RYTM has a high of $122.20 and a low of $45.90.
As of this writing, RYTM has an earnings estimate of -$0.75 per share for the current quarter. EPS was calculated based on a consensus of 11.0 estimates, with a high estimate of -$0.27 per share and a lower estimate of -$0.96. The company reported an EPS of -$0.72 in the last quarter
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. RYTM’s latest balance sheet shows that the firm has $294.86M in Cash & Short Term Investments as of fiscal 2021. There were $2.55M in debt and $43.43M in liabilities at the time. Its Book Value Per Share was $2.23, while its Total Shareholder’s Equity was $284.15M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RYTM is Buy with a score of 4.67.
